Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
Rhea-AI Summary
Anaptys (Nasdaq: ANAB) announced that chief financial officer Chris Murphy will present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, Sept. 15, 2026, at 3:30 p.m. ET. A live webcast and at least 30-day replay will be accessible via the investor section of Anaptys’ website.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 12 | Q1 earnings | Neutral | -4.4% | Reported collaboration revenue, cash, net loss, royalties, repurchase plan, and PDUFA date. |
| May 11 | Leadership appointment | Positive | -2.0% | Appointed Christopher M. Murphy CFO and Owen Hughes director, effective May 11. |
| May 04 | Conference participation | Neutral | -0.7% | Announced CEO participation in a fireside chat at H.C. Wainwright royalty conference. |
| Apr 28 | Clinical publication | Positive | -5.7% | Reported pivotal phase III imsidolimab study publication and FDA BLA target date. |
| Apr 24 | Court ruling | Positive | +14.8% | Dismissed Tesaro's anticipatory breach claim in Delaware Chancery Court. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Historical reactions were negative for four of five events, including positive or neutral announcements; the favorable court ruling was the exception.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Chris Murphy, chief financial officer, is scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, Sept. 15, 2026. The presentation is scheduled to begin at 3:30pm ET.
A live webcast of the presentation will be available on the investor section of the Anaptys website at https://ir.anaptysbio.com/presentations-and-events. A replay of the webcast will be available for at least 30 days following the event.
About Anaptys
Anaptys manages the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, with a focus on protecting and returning the value of its royalties to shareholders. To learn more, visit www.AnaptysBio.com or follow us on LinkedIn.
Contact:
Chris Murphy
Chief Financial Officer
investors@anaptysbio.com